FDA
-
-
-
-
-
-
-
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
-
-
-
-
-
-
-
New Breast Cancer Therapy to Reduce Risk of Recurrence and Improve Disease-Free Survival Now Available in Thailand
-
-
-
-
-
-
-
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
-
-
-
-
-
-
-
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
-
-
-
-
-
-
-
Puma Biotechnology to Present Clinical Data on Neratinib at the AACR Annual Meeting 2025
-
-
-
-
-
-
-
Puma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2024 Financial Results
-
-
-
-
-
-
-
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
-
330,167 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

